Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Cancer Investigation|January 1, 1994
Phase II evaluation of amonafide in advanced sarcoma: a Southwest Oncology Group studyS S Buys, B Metch, S P Balcerzak, et al.
Cancer Treatment Reports|June 1, 1985
Comparison of methotrexate and cisplatin for patients with advanced squamous cell carcinoma of the head and neck region: a Southwest Oncology Group StudyW E Grose, D E Lehane, D O Dixon, et al.
Cancer Chemotherapy Reports|March 1, 1975
Evaluation of daunorubicin (NSC-82151) and methotrexate (NSC-740) in combination as a remission maintenance regimen in the treatment of acute leukemiaB Humphrey, D J Fernbach, A A Razek, et al.
Arteriosclerosis (Dallas, Tex.)|March 1, 1983
Racial differences in platelet survival time in patients with symptomatic coronary atherosclerosisL C Thomas, T D Giles, W J Stuckey, et al.
Cancer|May 15, 1991
A weekly cisplatin-based induction regimen for extensive non-small cell lung cancer. A Southwest Oncology Group studyC S Higano, J Crowley, R B Livingston, et al.
Investigational New Drugs|January 1, 1984
Southwest Oncology Group study of Mitoxantrone for treatment of patients with advanced squamous cell carcinoma of the head and neckD E Mattox, G M Clark, S P Balcerzak, et al.
Investigational New Drugs|April 1, 1992
Phase II evaluation of didemnin B in advanced adenocarcinoma of the kidney. A Southwest Oncology Group studyS A Taylor, P Goodman, E D Crawford, et al.
Investigational New Drugs|May 1, 1993
Mitoxantrone (dihydroxyanthracenedione) in acute leukemia. An evaluation of two treatment schedules by the Southwest Oncology GroupJ H Saiki, W J Stuckey, J W Athens, et al.
American Journal of Clinical Oncology|December 1, 1982
Adriamycin combined with 10-day Ara-C, vincristine, and prednisone (10-day ADOAP) in the treatment of adult acute leukemia patients under fifty years of age. A Southwest Oncology Group StudyS L Schreiter, M Amare, W J Stuckey, et al.
Cancer Treatment Reports|December 1, 1977
Comparative trial of combination chemotherapy in extensive squamous carcinoma of the lung: a Southwest Oncology Group StudyR B Livingston, L Helibrun, D Lehane, et al.
Pageof 3